Skip to content
akaturk Academic measurement
Sign in Register

Academician

EGEMEN FOTO

DOKTOR ÖĞRETİM ÜYESİ

NECMETTİN ERBAKAN ÜNİVERSİTESİ FEN FAKÜLTESİ BİYOTEKNOLOJİ BÖLÜMÜ

  • Ana Dal Fen Bilimleri ve Matematik Temel Alanı
  • Yan Dal Biyoloji

A quick look at recorded outputs — details below.

  • Articles 20
  • Projects 0
  • Books 0
  • Proceedings 0
  • Patents 0
  • Artistic 0
Scopus (SJR) Q1 8 Q2 10 Q3 6 Q4 2
WoS (JCR) Q1 7 Q2 0 Q3 11 Q4 8
TR Index 1 articles

Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.

Top 1% articles 0
Top 10% articles 0
Avg percentile 60.7%
Top 1% share 0.0%
Top 10% share 0.0%

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

Index filters

20 publications total

Scopus (SJR)
Q1 8 Q2 10 Q3 6 Q4 2
WoS (JCR)
Q1 7 Q2 0 Q3 11 Q4 8
TR Index
1 articles

Article list

  1. 2024 Antibacterial potentials of carbon dots immobilized on chitosan and glass surfaces International Journal of Biological Macromolecules DOI 10.1016/j.ijbiomac.2023.128586 YÖKSİS SJR Q1 JCR Q1 OpenAlex 85.1%
  2. 2024 Design, Synthesis, and Biological Evaluation of Some Novel Retinoid Derivatives Letters in Drug Design & Discovery DOI 10.2174/0115701808243556231017055256 YÖKSİS SJR Q3 JCR Q4 OpenAlex 9.3%
  3. 2024 Arap Zamkı Modifiyeli Manyetik Nanopartiküller ile Sulu Çözeltilerden Kromat İyonlarının Uzaklaştırılması Karaelmas Fen ve Mühendislik Dergisi DOI 10.7212/karaelmasfen.1421942 YÖKSİS TR Index OpenAlex 13.6%
  4. 2022 Biological activity and ADME/Tox prediction of some 2-substituted benzoxazole derivatives BIOORGANIC CHEMISTRY DOI 10.1016/j.bioorg.2022.105756 YÖKSİS SJR Q1 JCR Q1 OpenAlex 73.6%
  5. 2022 EVALUATİON OF MUTAGENİC ACTİVİTİES OF ANTİMİCROBİAL BENZOXAZOLE DERİVATİVES PHARMACEUTİCAL CHEMİSTRY JOURNAL DOI 10.1007/s11094-022-02776-y YÖKSİS SJR Q4 JCR Q4 OpenAlex 44.5%
  6. 2021 Antioxidative and antiproliferative effects of propolis-reduced silver nanoparticles Advances In Nano Research DOI 10.12989/anr.2021.10.2.139 YÖKSİS SJR Q1 JCR Q1 OpenAlex 69.5%
  7. 2021 Discovery of 5-(or 6)-benzoxazoles and oxazolo[4,5-b]pyridines as novel candidate antitumor agents targeting hTopo IIα Bioorganic Chemistry DOI 10.1016/j.bioorg.2021.104913 YÖKSİS SJR Q2 JCR Q1 OpenAlex 82.2%
  8. 2020 Benzoxazines as new human topoisomerase I inhibitors and potential poisons DARU Journal of Pharmaceutical Sciences DOI 10.1007/s40199-019-00315-x YÖKSİS SJR Q2 JCR Q3 OpenAlex 77.0%
  9. 2018 Biological evaluation and pharmacophore modeling of some benzoxazoles and their possible metabolites Archiv der Pharmazie DOI 10.1002/ardp.201700265 YÖKSİS SJR Q2 JCR Q3 OpenAlex 63.7%
  10. 2018 Inhibition of DNA Topoisomerases by a Series of Benzoxazoles and their Possible Metabolites Letters in Drug Design Discovery DOI 10.2174/1570180815666180124143246 YÖKSİS SJR Q3 JCR Q4 OpenAlex 41.2%
  11. 2017 Vibrational Spectroscopic Analysis Molecular Dynamics Simulations and Molecular Docking Study of 5 Nitro 2 Phenoxymethyl Benzimidazole Journal of Molecular Structure DOI 10.1016/j.molstruc.2016.09.059 YÖKSİS SJR Q3 JCR Q3 OpenAlex 71.8%
  12. 2014 Genotoxic potentials and eukaryotic DNA topoisomerase I inhibitory effects of some benzoxazine derivatives Medicinal Chemistry Research DOI 10.1007/s00044-013-0658-5 YÖKSİS SJR Q2 JCR Q3 OpenAlex 68.2%
  13. 2013 Benzothiazole derivatives as human DNA topoisomerase II inhibitors Medicinal Chemistry Research DOI 10.1007/s00044-013-0577-5 YÖKSİS SJR Q2 JCR Q3 OpenAlex 72.9%
  14. 2024 Antibacterial potentials of carbon dots immobilized on chitosan and glass surfaces International Journal of Biological Macromolecules DOI 10.1016/j.ijbiomac.2023.128586 YÖKSİS SJR Q1 JCR Q1 OpenAlex 85.1%
  15. 2022 Biological activity and ADME/Tox prediction of some 2-substituted benzoxazole derivatives. Bioorganic chemistry DOI 10.1016/j.bioorg.2022.105756 YÖKSİS SJR Q1 JCR Q1 OpenAlex 73.6%
  16. 2022 Evaluation of Mutagenic Activities of Antimicrobial Benzoxazole Derivatives PHARMACEUTICAL CHEMISTRY JOURNAL DOI 10.1007/s11094-022-02776-y YÖKSİS SJR Q4 JCR Q4 OpenAlex 44.5%
  17. 2021 Antioxidative and Antiproliferative Effects of Propolis-reduced Silver Nanoparticles ADVANCES IN NANO RESEARCH DOI 10.12989/anr.2021.10.2.139 YÖKSİS SJR Q1 JCR Q1 OpenAlex 68.5%
  18. 2020 Benzoxazines as new human topoisomerase I inhibitors and potential poisons DARU Journal of Pharmaceutical Sciences DOI 10.1007/s40199-019-00315-x YÖKSİS SJR Q2 JCR Q3 OpenAlex 77.0%
  19. 2018 Biological evaluation and pharmacophore modeling of some benzoxazoles and their possible metabolites ARCHIV DER PHARMAZIE YÖKSİS SJR Q2 JCR Q3
  20. 2018 Inhibition of DNA Topoisomerases by a Series of Benzoxazoles and their Possible Metabolites Letters in Drug Design Discovery DOI 10.2174/1570180815666180124143246 YÖKSİS SJR Q3 JCR Q4 OpenAlex 41.2%

Back to academicians